Trial Profile
A phase II study of SHP 627 in patients with focal segmental glomerulosclerosis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2014
Price :
$35
*
At a glance
- Drugs FT 011 (Primary)
- Indications Focal segmental glomerulosclerosis
- Focus Therapeutic Use
- 09 Sep 2014 New trial record